Schizophrenia: all 3,539 studies

Page 11 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.

• Oxytocin and Social Cognition in SchizophreniaCompletedNCT00884897Phase 2Results posted
• Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic PatientsCompletedNCT00882518Phase 3Results posted
• Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With SchizophreniaCompletedNCT00862992Phase 2Results posted
• Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic SyndromeTerminatedNCT00857818Phase 3Results posted
• Safety Study of Sertindole Versus Risperidone Under Normal Conditions of UseCompletedNCT00856583Phase 3Results posted
• Seroquel XR in Adults With SchizophreniaTerminatedNCT00852631Phase 3Results posted
• Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED)CompletedNCT00848484Phase 2Results posted
• A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic PatientsCompletedNCT00845026Phase 2Results posted
• A Study of Cariprazine in Patients With Chronic Stable SchizophreniaCompletedNCT00839852Phase 2Results posted
• Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated HypertriglyceridemiaCompletedNCT00833976Phase 4Results posted
• Effects of Eszopiclone on Sleep-dependent Learning in SchizophreniaCompletedNCT00833547Not applicableResults posted
• A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)CompletedNCT00827918Phase 2Results posted
• D-serine for the Schizophrenia ProdromeCompletedNCT00826202Phase 2Results posted
• An Open Trial of Allopurinol in Patients With Poorly Responsive SchizophreniaCompletedNCT00823199Not applicableResults posted
• Biomarkers in SchizophreniaCompletedNCT00817336Phase 2Results posted
• The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)CompletedNCT00816907Phase 4Results posted
• Cognitive Behavior Therapy and Work OutcomeCompletedNCT00810355Not applicableResults posted
• Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and PredictorsCompletedNCT00802919Phase 4Results posted
• Comparison of Optimal Antipsychotic Treatments for Adults With SchizophreniaCompletedNCT00802100Phase 4Results posted
• Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in SchizophreniaCompletedNCT00797277Phase 3Results posted
• Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for SchizophreniaTerminatedNCT00794963Not applicableResults posted
• Pilot Trial of Naltrexone for Obesity in Women With SchizophreniaCompletedNCT00793780Not applicableResults posted
• Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.CompletedNCT00790192Phase 3Results posted
• Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic SchizophreniaCompletedNCT00789698Phase 3Results posted
• Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic ParticipantsCompletedNCT00784238Phase 4Results posted
• Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)CompletedNCT00779506Phase 4Results posted
• Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With SchizophreniaCompletedNCT00772005Phase 2Results posted
• Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic ParticipantsCompletedNCT00761605Phase 4Results posted
• Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic RemissionCompletedNCT00761579Phase 4Results posted
• PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute SchizophreniaCompletedNCT00761189Phase 4Results posted
• An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With SchizophreniaCompletedNCT00757705Phase 4Results posted
• Artemisinin to Reduce The Symptoms of SchizophreniaCompletedNCT00753506Not applicableResults posted
• One-Year Trial Of Oral Ziprasidone In Patients With Metabolic SyndromeTerminatedNCT00748566Phase 4Results posted
• Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for SchizophreniaCompletedNCT00742079Phase 4Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00731549Phase 3Results posted
• Pregnenolone for Cognitive and Negative Symptoms in SchizophreniaCompletedNCT00728728Phase 2Results posted
• Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001)CompletedNCT00725075Phase 2Results posted
• A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With AgitationCompletedNCT00723606Phase 3Results posted
• L-arginine in Treatment as Usual in SchizophreniaCompletedNCT00718510Not applicableResults posted
• Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in SchizophreniaTerminatedNCT00712270Phase 4Results posted
• Functional Rehabilitation for Older Patients With SchizophreniaTerminatedNCT00712075Not applicableResults posted
• Modafinil Effects on Cognition in Schizophrenia PatientsCompletedNCT00711464Phase 4Results posted
• Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedNCT00711269Phase 3Results posted
• Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight GainCompletedNCT00709202Phase 2Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00706654Phase 3Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00705783Phase 3Results posted
• Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of SchizophreniaCompletedNCT00694707Phase 2Results posted
• Study to Demonstrate Cognitive Enhancing Effects of BF2.649CompletedNCT00690274Phase 2Results posted
• Demonstrate the Effects of Pramlintide on Weight Reduction in SchizophreniaCompletedNCT00690235Phase 4Results posted
• Biomarker Study of Acamprosate in SchizophreniaCompletedNCT00688324Phase 4Results posted
• Cognitive-Behavioral Therapy in Veterans With SchizophreniaCompletedNCT00688259Not applicableResults posted
• Phase IIA Study in Patients With SchizophreniaCompletedNCT00686998Phase 2Results posted
• Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)TerminatedNCT00686699Phase 2Results posted
• Schizophrenic Patients in Integrated CareTerminatedNCT00681629Phase 4Results posted
• A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs)CompletedNCT00677898Not applicableResults posted
• Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With SchizophreniaTerminatedNCT00669903Phase 2Results posted
• Effects of Oxytocin Nasal Spray on Social AffiliationCompletedNCT00663039Phase 2Results posted
• Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible DoseTerminatedNCT00660595Phase 3Results posted
• Effect of Single Dose Intranasal Insulin On Cognitive FunctionCompletedNCT00646581Phase 4Results posted
• Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With SchizophreniaCompletedNCT00645944Not applicableResults posted
• A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With SchizophreniaCompletedNCT00645099Phase 3Results posted
• Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00644969Phase 3Results posted
• A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of SchizophreniaCompletedNCT00642369Not applicableResults posted
• Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable SchizophreniaCompletedNCT00641745Phase 3Results posted
• Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With SchizophreniaCompletedNCT00640601Phase 3Results posted
• Quetiapine Extended Release Depression SymptomsCompletedNCT00640562Phase 3Results posted
• A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With SchizophreniaCompletedNCT00640510Phase 3Results posted
• Staccato Loxapine in Agitated Patients With SchizophreniaCompletedNCT00628589Phase 3Results posted
• Treating Cognition in Schizophrenia With Atomoxetine and Cognitive RemediationCompletedNCT00628394Phase 4Results posted
• A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar DisorderCompletedNCT00621777Phase 4Results posted
• Lurasidone HCl A Phase 3 Study of Patients With Acute SchizophreniaCompletedNCT00615433Phase 3Results posted
• Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of SchizophreniaCompletedNCT00611806Phase 4Results posted
• A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With SchizophreniaCompletedNCT00604279Phase 3Results posted
• Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to RisperidoneCompletedNCT00600756Phase 3Results posted
• Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With SchizophreniaCompletedNCT00595504Phase 4Results posted
• Sodium Oxybate in Schizophrenia With InsomniaCompletedNCT00594256Phase 2Results posted
• A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory PsychosisTerminatedNCT00591318Phase 1/2Results posted
• Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With SchizophreniaCompletedNCT00590577Phase 3Results posted
• Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With SchizophreniaCompletedNCT00589914Phase 3Results posted
• Cannabidiol Treatment of Cognitive Dysfunction in SchizophreniaCompletedNCT00588731Phase 2Results posted
• Efficacy of Social Cognition Training in SchizophreniaCompletedNCT00587561Not applicableResults posted
• Treatment of Schizophrenic Patients With ZiprasidoneCompletedNCT00579670Results posted
• Intranasal Insulin Treatment in Patients With SchizophreniaCompletedNCT00575666Phase 4Results posted
• First Episode Schizophrenia and Cannabis-Related Disorder StudyCompletedNCT00573287Not applicableResults posted
• Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With PlaceboTerminatedNCT00570063Phase 2Results posted
• An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With SchizophreniaCompletedNCT00566631Phase 3Results posted
• Study Evaluating Vabicaserin in Subjects With SchizophreniaCompletedNCT00563706Phase 2Results posted
• Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With SchizophreniaCompletedNCT00560937Not applicableResults posted
• Comparison of Varenicline and Placebo for Smoking Cessation in SchizophreniaCompletedNCT00554840Phase 2Results posted
• Lurasidone HCl: A Phase 3 Study of Patients With Acute SchizophreniaCompletedNCT00549718Phase 3Results posted
• Varenicline Effects In Schizophrenic SmokersCompletedNCT00548470Phase 4Results posted
• The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) GenotypeTerminatedNCT00548327Phase 2Results posted
• The Effects of Rimonabant, on Weight and Metabolic Risk FactorsTerminatedNCT00547118Phase 2Results posted
• High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to RisperidoneCompletedNCT00539071Phase 4Results posted
• Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to ZiprasidoneCompletedNCT00538642Not applicableResults posted
• Non Interventional Study In Bipolar Disorder And Schizophrenia With ZeldoxCompletedNCT00538629Results posted
• Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver DiseaseCompletedNCT00535145Phase 4Results posted
• Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to PaliperidoneCompletedNCT00535132Phase 4Results posted
• Early Detection and Intervention for the Prevention of PsychosisCompletedNCT00531518Not applicableResults posted
• An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With SchizophreniaCompletedNCT00524043Phase 4Results posted

← Schizophrenia overview